QT interval in cardiac amyloidosis

Area of Science:

• Cardiology
• Electrophysiology
• Cardiac Imaging

Background:

• Cardiac amyloidosis is a progressive condition characterized by amyloid protein deposition in the heart.
• Left ventricular (LV) thickening is a hallmark of cardiac amyloidosis, potentially affecting cardiac function and electrical properties.
• The association between cardiac amyloidosis, QT interval abnormalities, and ventricular arrhythmias requires further investigation.

Purpose of the Study:

• To determine if cardiac amyloidosis is associated with QT interval abnormalities.
• To assess the incidence of ventricular arrhythmias in patients with cardiac amyloidosis.
• To investigate the relationship between LV thickening in cardiac amyloidosis and cardiac electrical repolarization.

Main Methods:

• A controlled study comparing 30 patients with biopsy-proven systemic amyloidosis and cardiac involvement to 30 healthy controls.
• Utilized M-mode and 2D echocardiography to assess LV structure and mass.
• Performed 24-hour Holter monitoring to evaluate QT interval, corrected QT (QTc) dispersion, and arrhythmias.

Main Results:

• All cardiac amyloidosis patients exhibited LV wall thickening, with significantly increased LV mass and LV mass/body surface area ratio compared to controls.
• While the maximum QTc was greater in cardiac amyloidosis patients, there were no significant differences in max QT interval or QTc dispersion between groups.
• The incidence of arrhythmias was similar between patients with cardiac amyloidosis and the control group.

Conclusions:

• Cardiac amyloidosis is associated with LV thickening and a prolonged QTc interval.
• Despite prolonged QTc, cardiac amyloidosis does not lead to increased QTc dispersion, suggesting uniform repolarization.
• Patients with cardiac amyloidosis do not exhibit a higher risk of ventricular arrhythmias compared to healthy individuals.